| II-54 Petra Jauslin Population Pharmacokinetic Analysis of Tildrakizumab, an Anti-IL-23 Antibody, in Healthy Volunteers and Subjects with Psoriasis Wednesday 15:50-17:20 |
| II-54 Petra Jauslin Population Pharmacokinetic Analysis of Tildrakizumab, an Anti-IL-23 Antibody, in Healthy Volunteers and Subjects with Psoriasis Wednesday 15:50-17:20 |